Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News FDA approves Bayer’s Lynkuet, a first-in-class dual NK-1/NK-3 antagonist for menopausal hot flashes Find out how Bayer’s Lynkuet is changing menopause care with the first dual-neurokinin receptor antagonist approved by the FDA for hot flashes! bySoujanya RaviOctober 24, 2025